LASA SUPERGENERICS LTD vs Laurus Labs Limited

A side-by-side comparison of LASA SUPERGENERICS LTD (LASA) and Laurus Labs Limited (LAURUSLABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Laurus Labs Limited leads LASA vs LAURUSLABS on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability04
  • Growth01
  • Size & financial health13

Valuation

LASA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
125.08
0.57
P/B ratio
19.74
3.83%
Dividend yield
0.10%
₹-6.80
EPS
₹16.47

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-68.70%
Return on equity
16.77%
-57.64%
Return on capital
17.58%
-112.98%
EBITDA margin
26.09%
-135.60%
Net margin
13.07%

Growth

LAURUSLABS takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-42.17%
Revenue CAGR (3Y)
4.09%
—
Profit CAGR (3Y) even
3.91%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹26 Cr
Market cap
₹1.11L Cr
₹25 Cr
Revenue
₹6,813 Cr
₹-34 Cr
Net profit
₹890 Cr
0.20
Debt / equity
0.45
LASA SUPERGENERICS LTD
  • + ["Stock is trading at 0.52 times its book value"]
  • − ["The company has delivered a poor sales growth of -34.0% over past five years.", "Company has a low return on equity of -29.4% over last 3 years.", "Company reported a net loss of ₹34 Cr in its latest financial year."]
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 21.00 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
LASA SUPERGENERICS LTD full analysis Laurus Labs Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.